Concord Biotech Fundamental Analysis
CONCORDBIO
556.34.70 (-0.84%)
Last updated on 19 Nov, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Concord Biotech Fundamentals
P/E Ratio
41.56
P/B Ratio
5.63
Div. Yield
0.67
Sector P/E
40.25
Sector P/B
2.53
Sec. Div. Yield
0.53
Concord Biotech Fundamentals is currently trading with a P/E Ratio of 41.56, compared to the sector average of 40.25. Its P/B Ratio stands at 5.63, while the sector’s is 2.53. In terms of returns, the stock offers a Dividend Yield of 0.67%, which is than the sector’s 0.53%.
Concord Biotech Score Card
Price
Expensive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Concord Biotech reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Concord Biotech Associated Pages
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in CONCORDBIO
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in CONCORDBIO
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade